Xenogen adds Lumina Imaging System to its IVIS product line

By Lisa Kerner

Erie, Pa., March 31 - Xenogen Corp. launched its IVIS Lumina Imaging System, an optical imaging system that provides both in vitro and in vivo fluorescent and bioluminescent imaging capabilities.

The IVIS Lumina System is the company's latest product in its platform of IVIS systems, including the IVIS 3D System, which was launched in September 2005, according to a company news release.

Xenogen said its optical imaging technology is designed to help researchers visualize, track and understand biological processes in living animals, non-invasively and in real time.

"With the IVIS Lumina System, we want to give researchers the opportunity to purchase an IVIS system designed to generate high-quality data at an affordable price," president Pamela R. Contag said in the release.

"The IVIS Lumina System allows researchers to affordably utilize Xenogen's advanced technology for drug discovery and development."

Xenogen is an Alameda, Calif.-based biotechnology company offering an integrated suite of optical real-time in vivo imaging and genetic modification technologies.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.